[The climacteric--physiology or pathology?]
- PMID: 2679445
- DOI: 10.1007/BF02417633
[The climacteric--physiology or pathology?]
Abstract
Nearly 30 years of a woman's life is spent after cessation of the reproductive function and about 30% of the female population in Europe is postmenopausal. The medical infirmities resulting from estrogen deprivation among postmenopausal women take a high toll. The greatest number of hip fractures because of osteoporosis occur in this group, resulting in a high death (20%-30%) and morbidity rate. Estrogen deprivation leads to a change of the lipid metabolism with acceleration of arteriosclerosis. While the "estrogen forever" era closed with a striking rise in the incidence of adenocarcinoma of the endometrium, combined estrogen-gestagen treatment drastically decreases the incidence of endometrial and breast carcinoma. Therefore, physicians must be aware of the benefits of estrogen-gestagen treatment and act appropriately.
Similar articles
-
The menopause: benefits and risks of estrogen-progestogen replacement therapy.Fertil Steril. 1982 Apr;37(4):457-74. doi: 10.1016/s0015-0282(16)46149-2. Fertil Steril. 1982. PMID: 7040116 Review.
-
[Peroral treatment with natural human estrogens in the climacteric].Ugeskr Laeger. 1980 Sep 15;142(38):2497-500. Ugeskr Laeger. 1980. PMID: 7445154 Danish.
-
Estrogen and progestin supplementation.Nurse Pract. 1995 Mar;20(3):63-6. Nurse Pract. 1995. PMID: 7761042 No abstract available.
-
[Principles of hormone substitution in the postmenopause period].Schweiz Rundsch Med Prax. 1991 Apr 16;80(16):431-4. Schweiz Rundsch Med Prax. 1991. PMID: 2038641 German.
-
Menopause and estrogen replacement therapy.Psychiatr Clin North Am. 1989 Mar;12(1):133-52. Psychiatr Clin North Am. 1989. PMID: 2652104 Review.